<h4>Background</h4>Alzheimer's disease (AD) is increasingly recognized as a disorder involving not only amyloid and tau pathology but also glial activation and neuroinflammation. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.